Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108)
Titel:
Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108)
Auteur:
Klinghammer, K. Gauler, T. Dietz, A. Grünwald, V. Stöhlmacher, J. Knipping, S. Schroeder, M. Guntinas-Lichius, O. Frickhofen, N. Lindeman, H.-W. Fietkau, R. Haxel, B. Große-Thie, C. Maschmeyer, G. Zipfel, M. Martus, P. Knoedler, M. Keilholz, U.